Nonsteroidal anti-inflammatory drugs and hypotension among patients hospitalized for invasive group A streptococcal disease [2]

Annals of Epidemiology

Volumn 13, Issue 7, 2003, Pages 543-544

  Mulla, Zuber D ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CLINDAMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANTIBIOTIC THERAPY; BACTERIUM ISOLATION; DEMOGRAPHY; HEALTH SURVEY; HOSPITALIZATION; HUMAN; HYPOTENSION; LETTER; LOGISTIC REGRESSION ANALYSIS; NONHUMAN; PATIENT INFORMATION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; UNITED STATES;

EID: 0042661058     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(03)00071-1     Document Type: Article

References (6)

1. Centers for Disease Control. Summary of Notifiable Diseases - United States, 2000. Morb Mortal Wkly Rep. XIX:2002;3.
2. Hoge C.W., Schwartz B., Talkington D.F., Breiman R.F., MacNeill E.M., Englender S.J. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome - A retrospective population-based study. JAMA. 269:1993;384-389.
3. Stevens D.L. Could nonsteroidal anti-inflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis. 21:1995;977-980.
4. Schlievert P.M., Assimacopoulos A.P., Cleary P.P. Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. J Lab Clin Med. 127:1996;13-22.
5. Stevens D.L., Bryant A.E., Hackett S.P., Chang A., Peer G., Kosanke S., et al. Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure. J Infect Dis. 173:1996;619-626.
6. Mulla ZD, Leaverton PE, Wiersma ST. Invasive group A streptococcal infections in Florida. South Med J (in press).